XingImaging has been selected as the Imaging Core Lab for the Alzheimer’s Tau Platform (ATP)—a groundbreaking, multi-arm, ...
Korsana’s lead program uses a next-generation shuttling technology to improve delivery into the brain and lower the incidence of amyloid-related imaging abnormalities.
A new entrant in the race to shepherd antibodies for Alzheimer’s disease across the blood-brain barrier has emerged. | A new entrant in the race to shepherd antibodies for Alzheimer’s disease across ...
A new study study finds that brain swelling (ARIA-E) from Alzheimer's drugs identifies the regions where amyloid plaques are being cleared most effectively.
A new Alzheimer's treatment side effect that results in brain swelling may have an upside, according to a new study from Houston Methodist Research Institute. The research finds that beta amyloid—a ...
A new Alzheimer's treatment side effect that results in brain swelling may have an upside, according to a new study from Houston Methodist Research ...
Morning Overview on MSN
Could attacking toxic protein chains finally slow neurodegenerative disease?
Researchers are testing a fundamentally different strategy against neurodegenerative disease: instead of clearing protein ...
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...
Neurophet AQUA AD Plus quantitatively analyses MRI and PET scans to inform therapy eligibility, monitor treatment-related ...
A new Harvard study shows how lithium, one of the simplest elements, may protect against and even reverse Alzheimer’s — and what that could mean for your brain.
The drug would need to be taken long before symptoms first appear—but it could be used to help protect at-risk individuals.
While physicians and scientists have long known Alzheimer's disease involves the buildup of toxic protein fragments in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results